Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTHCARE CORPNHC · Entity 355 | Director | June 22, 2026 | June 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTHCARE CORP
Report date June 22, 2026 · Filed June 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of Common StockSEC Table I · non-derivative | Direct | 65,595 |
Reported balance
After 2026-06-22 transaction · row 1
1 source rowRow 1 · 2026-06-22 · Sale · Disposed 5,937 · Balance 65,595 |
| Option to Purchase Common Stock [2022 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $69.19 · Expires 2027-05-04 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-06-22 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 7,500 |
| Option to Purchase Common Stock [2023 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $55.75 · Expires 2028-05-03 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-06-22 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 7,500 |
| Option to Purchase Common Stock [2024 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $96.03 · Expires 2029-05-08 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-06-22 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 7,500 |
| Option to Purchase Common Stock [2025 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $94.66 · Expires 2030-05-07 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-06-22 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 7,500 |
| Option to Purchase Common Stock [2026 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $171.42 · Expires 2031-05-06 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-06-22 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 7,500 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2026 Filed Jun 23, 2026 20:07 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 5,937 | $200.00 | $1,187,400.00 |
DisclosureSEC source: 0001437749-26-021438 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,595 Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:03 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 1,563 | $199.98 | $312,560.93 |
DisclosureSEC source: 0001437749-26-021139 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,532 Read SEC document |
| May 07, 2026 Filed May 7, 2026 22:03 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2026 Grant] · Derivative | 7,500 | $0.00 Strike: $171.42 | $0.00 |
DisclosureSEC source: 0001437749-26-015689 · rdgdoc.xml · derivative · entry 6 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2031-05-06 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| April 30, 2026 Filed May 1, 2026 20:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2021 Grant] · Derivative | 7,500 | $0.00 Strike: $71.64 | $0.00 |
DisclosureSEC source: 0001437749-26-014489 · rdgdoc.xml · derivative · entry 2 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2026-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| April 30, 2026 Filed May 1, 2026 20:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 7,500 | $71.64 | $537,300.00 |
DisclosureSEC source: 0001437749-26-014489 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 21:02 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 7,500 | $138.52 | $1,038,873.00 |
DisclosureSEC source: 0001437749-25-036441 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,595 Read SEC document |
| November 12, 2025 Filed Nov 12, 2025 23:42 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 5,500 | $133.00 | $731,500.00 |
DisclosureSEC source: 0001437749-25-034547 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,095 F1 · balance_after: Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form. Read SEC document |
| May 08, 2025 Filed May 9, 2025 20:23 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2024 Grant] · Derivative | 7,500 | $0.00 Strike: $94.66 | $0.00 |
DisclosureSEC source: 0001437749-25-015791 · rdgdoc.xml · derivative · entry 6 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2030-05-07 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 8, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| April 25, 2025 Filed Apr 28, 2025 20:42 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2020 Grant] · Derivative | 5,500 | $0.00 Strike: $64.64 | $0.00 |
DisclosureSEC source: 0001437749-25-013348 · rdgdoc.xml · derivative · entry 2 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,500 shares Expires 2025-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| April 25, 2025 Filed Apr 28, 2025 20:42 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 5,500 | $64.64 | $355,520.00 |
DisclosureSEC source: 0001437749-25-013348 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 09, 2024 Filed May 13, 2024 21:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2024 Grant] · Derivative | 7,500 | $0.00 Strike: $96.03 | $0.00 |
DisclosureSEC source: 0001437749-24-016304 · rdgdoc.xml · derivative · entry 6 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-05-08 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 9, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 03, 2024 Filed May 6, 2024 21:32 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $77.92 | $0.00 |
DisclosureSEC source: 0001437749-24-014861 · rdgdoc.xml · derivative · entry 2 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2024-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 03, 2024 Filed May 6, 2024 21:32 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 7,500 | $77.92 | $584,400.00 |
DisclosureSEC source: 0001437749-24-014861 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 08, 2023 Filed Dec 11, 2023 21:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 7,500 | $88.50 | $663,750.00 |
DisclosureSEC source: 0001437749-23-034078 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,595 Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 21:50 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 7,500 | $85.50 | $641,250.00 |
DisclosureSEC source: 0001437749-23-033778 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,095 Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 21:32 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2020 Grant] · Derivative | 2,000 | $0.00 Strike: $64.64 | $0.00 |
DisclosureSEC source: 0001437749-23-027420 · rdgdoc.xml · derivative · entry 3 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 7,500 shares Expires 2025-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 21:32 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 2,000 | $64.64 | $129,280.00 |
DisclosureSEC source: 0001437749-23-027420 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 04, 2023 Filed May 4, 2023 22:18 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2023 Grant] · Derivative | 7,500 | $0.00 Strike: $55.75 | $0.00 |
DisclosureSEC source: 0001437749-23-012625 · rdgdoc.xml · derivative · entry 6 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2028-05-03 F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2022 Grant] · Derivative | 7,500 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-22-011327 · rdgdoc.xml · derivative · entry 7 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 F2 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001437749-22-011327 · rdgdoc.xml · derivative · entry 2 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2022-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 7,500 | $72.94 | $547,050.00 |
DisclosureSEC source: 0001437749-22-011327 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 19, 2021 Filed May 21, 2021 12:30 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $62.78 | $0.00 |
DisclosureSEC source: 0001437749-21-012988 · rdgdoc.xml · derivative · entry 2 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed May 21, 2021 12:30 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 7,500 | $62.78 | $470,850.00 |
DisclosureSEC source: 0001437749-21-012988 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2021 Filed May 7, 2021 19:55 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $71.64 | $0.00 |
DisclosureSEC source: 0001437749-21-011329 · rdgdoc.xml · derivative · entry 7 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-05-05 F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 21:58 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 1,913 | $79.00 | $151,127.00 |
DisclosureSEC source: 0001437749-21-006363 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,596 Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:41 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $64.64 | $0.00 |
DisclosureSEC source: 0001437749-20-010092 · rdgdoc.xml · derivative · entry 6 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2025-05-06 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| April 28, 2020 Filed Apr 29, 2020 21:55 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $61.25 | $0.00 |
DisclosureSEC source: 0001437749-20-008872 · rdgdoc.xml · derivative · entry 2 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2020 Filed Apr 29, 2020 21:55 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 5,000 | $61.25 | $306,250.00 |
DisclosureSEC source: 0001437749-20-008872 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 7, 2015. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 05, 2019 Filed Nov 6, 2019 21:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $61.25 | $0.00 |
DisclosureSEC source: 0001437749-19-021752 · rdgdoc.xml · derivative · entry 2 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 7,500 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2019 Filed Nov 6, 2019 21:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 2,500 | $61.25 | $153,125.00 |
DisclosureSEC source: 0001437749-19-021752 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2005 Stock Option Plan on May 7, 2015. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 09, 2019 Filed May 10, 2019 20:46 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $77.92 | $0.00 |
DisclosureSEC source: 0001437749-19-009505 · rdgdoc.xml · derivative · entry 6 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2024-05-08 F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 22:53 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $52.93 | $0.00 |
DisclosureSEC source: 0001437749-18-021352 · rdgdoc.xml · derivative · entry 2 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2019-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was amended November 8, 2018. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 22:53 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 7,500 | $52.93 | $396,975.00 |
DisclosureSEC source: 0001437749-18-021352 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2005 Stock Option Plan on May 8, 2014. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:22 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $61.90 | Not disclosed |
DisclosureSEC source: 0001437749-18-020630 · rdgdoc.xml · derivative · entry 11 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:22 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $61.90 | Not disclosed |
DisclosureSEC source: 0001437749-18-020630 · rdgdoc.xml · derivative · entry 10 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:22 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $72.94 | Not disclosed |
DisclosureSEC source: 0001437749-18-020630 · rdgdoc.xml · derivative · entry 9 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2022-05-08 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:22 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $72.94 | Not disclosed |
DisclosureSEC source: 0001437749-18-020630 · rdgdoc.xml · derivative · entry 8 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2022-05-08 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:22 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $62.78 | Not disclosed |
DisclosureSEC source: 0001437749-18-020630 · rdgdoc.xml · derivative · entry 7 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2021-06-01 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:22 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $62.78 | Not disclosed |
DisclosureSEC source: 0001437749-18-020630 · rdgdoc.xml · derivative · entry 6 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2021-06-01 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:22 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $61.25 | Not disclosed |
DisclosureSEC source: 0001437749-18-020630 · rdgdoc.xml · derivative · entry 5 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2020-05-06 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:22 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $61.25 | Not disclosed |
DisclosureSEC source: 0001437749-18-020630 · rdgdoc.xml · derivative · entry 4 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2020-05-06 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:22 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $52.93 | Not disclosed |
DisclosureSEC source: 0001437749-18-020630 · rdgdoc.xml · derivative · entry 3 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2019-05-07 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:22 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $52.93 | Not disclosed |
DisclosureSEC source: 0001437749-18-020630 · rdgdoc.xml · derivative · entry 2 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2019-05-07 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 14:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 5,000 | $76.48 | $382,400.00 |
DisclosureSEC source: 0001437749-18-015843 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,509 Read SEC document |
| June 14, 2018 Filed Jun 14, 2018 21:27 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 5,000 | $69.98 | $349,900.00 |
DisclosureSEC source: 0001437749-18-011852 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,509 Read SEC document |
| May 03, 2018 Filed May 4, 2018 18:03 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-18-008654 · rdgdoc.xml · derivative · entry 6 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 14, 2018 Filed Feb 15, 2018 15:56 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 4,865 | $0.00 Strike: $47.45 | $0.00 |
DisclosureSEC source: 0001437749-18-002642 · rdgdoc.xml · derivative · entry 2 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,865 shares Expires 2018-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2018 Filed Feb 15, 2018 15:56 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 4,865 | $47.45 | $230,844.25 |
DisclosureSEC source: 0001437749-18-002642 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 8, 2013. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| October 04, 2017 Filed Oct 5, 2017 15:57 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,635 | $0.00 Strike: $47.45 | $0.00 |
DisclosureSEC source: 0001437749-17-016858 · rdgdoc.xml · derivative · entry 2 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,865 Underlying: Common Stock · 7,500 shares Expires 2018-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of these options was inadvertently reported incorrectly on prior Form 4s. Read SEC document |
| October 04, 2017 Filed Oct 5, 2017 15:57 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 2,635 | $47.45 | $125,030.75 |
DisclosureSEC source: 0001437749-17-016858 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 8, 2013. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.